ArticleFrontiers in surgery2026
Case Report: Transrectal contrast-enhanced ultrasonography on preoperative evaluation of rectal neuroendocrine tumors: a 17-case preliminary study.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuroendocrine tumors of unknown primary: a case report and review of tumors with gastroenteropancreatic features.Journal of gastrointestinal oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the feasibility of transrectal ultrasound (TRUS) in the sonographic characterization and preoperative assessment of rectal neuroendocrine neoplasms (NENs). Methods: Retrospective analysis was performed on the transrectal ultrasound manifestations and clinical data of 17 patients with pathologically and immunohistochemically confirmed rectal NENs [8 cases of rectal neuroendocrine tumors [NETs, G1/G2] and 9 cases of rectal neuroendocrine carcinomas [NECs, G3]] between June 2020 and June 2025. These TRUS findings were compared with the ultrasound features of 31 contemporaneous cases of middle- and lower-segment rectal cancer. Results: All 8 rectal NETs (G1, G2) showed hypoechoic masses in the rectal mucosal and submucosal layers on TRUS, with clear borders in 8 cases, point-stripe blood flow signals in 7 cases, and round-shaped lymph nodes with a short diameter > 5 mm in 3 cases; contrast-enhanced ultrasound (CEUS) was performed in 6 cases, showing inhomogeneous hyperenhancement in 2 cases and homogeneous isoenhancement in 4 cases. Among the 9 rectal NECs (G3), 8 presented with localized irregular thickening of the rectal wall, 7 invaded perirectal tissues or organs, all lesions were hypoechoic or heteroechoic with muscularis propria infiltration, and 4 cases had enlarged local lymph nodes. Compared with rectal cancer, the distribution of T stage (T1 vs. T2-4) differed significantly ( Conclusions: Rectal NETs exhibit characteristic TRUS manifestations and require differentiation from polyps, adenocarcinomas, and inflammatory lesions. Transrectal contrast-enhanced ultrasonography (TR-CEUS), though not widely adopted, is feasible for the preoperative assessment of rectal NENs and may be valuable for follow-up after endoscopic resection to monitor recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.